DALI Medical Devices Ltd. is a biotechnology and medical devices startup based in Israel, delivering innovative injection solutions. Founded in 2003 by David Daily and Lior Raday, the company specializes in developing novel injectable drug delivery techniques. DALI's broad portfolio includes autoinjectors in partnership with E3D, Elcam Group and automatic-safe needles under the SAN® brand. Recently, the company introduced Synnect, a unique connectivity platform compatible with all prefilled and safety syringes, expanding the range of injectable drugs that can be easily connected. DALI has a proven track record of bringing its products to the market. The company's autoinjector has been launched with a blockbuster biologic, and the safety needle is set to be marketed next year. With a patient-centric approach, DALI's team of expert-and-attentive engineers customizes products to accommodate customer needs, believing in "Better Injections. Better Compliance. Better Care". Their user-friendly and safe drug delivery products aim to enhance the overall user experience in drug administration. At present, there is no specific information available regarding the last investment and investors involved for DALI Medical Devices Ltd.
There is no investment information
No recent news or press coverage available for DALI Medical Devices Ltd. .